Sliding Scale Insulin for Blood Glucose Above 150 mg/dL
For blood glucose levels above 150 mg/dL, a simplified sliding scale insulin ratio of 1:40 is not recommended as monotherapy; instead, implement a basal-bolus insulin regimen with correction doses for hyperglycemia based on individualized sensitivity factors. 1
Appropriate Insulin Management for Hyperglycemia
Basal-Bolus Approach
- Calculate total daily insulin dose at 0.3-0.5 units/kg/day for insulin-naive patients 1, 2
- Divide the total daily dose:
- Lower doses should be used for patients at higher risk of hypoglycemia (elderly, renal impairment, poor oral intake) 1
Correction Insulin for Hyperglycemia
For blood glucose >150 mg/dL, use a correction dose based on insulin sensitivity rather than a fixed 1:40 ratio. A simplified approach:
- For blood glucose >150 mg/dL: Add 2 units of rapid-acting insulin 1
- For blood glucose >250 mg/dL: Add 4 units of rapid-acting insulin 1, 2
Why Sliding Scale Alone Is Problematic
The American Diabetes Association strongly discourages using sliding scale insulin alone for managing diabetes 2. Research shows:
- Sliding scale insulin monotherapy is associated with a 3-fold higher risk of hyperglycemic episodes compared to other regimens 3
- Meta-analyses demonstrate that sliding scale insulin alone provides no benefit in blood glucose control and increases hyperglycemic events 4, 5
- Only 12% of sliding scale insulin injections successfully bring glucose levels to target range 6
Monitoring and Adjustment
- Monitor blood glucose before meals and at bedtime for patients who are eating 2
- If 50% of fasting glucose values are above target, increase basal insulin by 2 units 1, 2
- If experiencing hypoglycemia (<70 mg/dL), decrease basal insulin by 2 units 1, 2
- For hospitalized patients, target blood glucose range of 140-180 mg/dL is recommended 1
Special Considerations
- For patients on steroids (like prednisolone), standard sliding scale approaches are particularly ineffective due to the pattern of steroid-induced hyperglycemia (predominantly between midday and midnight) 7
- For elderly patients, a simplified approach may be used with less aggressive targets (90-150 mg/dL) 1
- For patients with renal impairment, insulin doses should be reduced by 20-25% 1, 2
Practical Implementation
- Calculate the patient's weight-based insulin requirement
- Implement basal insulin (once or twice daily)
- Add mealtime insulin for those who are eating
- Use correction doses for blood glucose >150 mg/dL based on insulin sensitivity
- Adjust doses every 1-2 days based on glucose patterns
The evidence clearly shows that using a physiologic insulin regimen with both basal and bolus components leads to better glycemic control and fewer complications than relying solely on sliding scale insulin for blood glucose above 150 mg/dL 1, 4, 5.